Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease

J Cell Mol Med. 2019 Nov;23(11):7124-7131. doi: 10.1111/jcmm.14562. Epub 2019 Sep 26.

Abstract

Cardiac progenitor cells are considered to be one of the most promising stem cells for heart regeneration and repair. The cardiac protective effect of CPCs is mainly achieved by reducing tissue damage and/or promoting tissue repair through a paracrine mechanism. Exosome is a factor that plays a major role in the paracrine effect of CPCs. By delivering microRNAs to target cells and regulating their functions, exosomes have shown significant beneficial effects in slowing down cardiac injury and promoting cardiac repair. Among them, miRNA-210 is an important anoxic-related miRNA derived from CPCs exosomes, which has great cardiac protective effect of inhibiting myocardial cell apoptosis, promoting angiogenesis and improving cardiac function. In addition, circulating miR-210 may be a useful biomarker for the prediction or diagnosis of related cardiovascular diseases. In this review, we briefly reviewed the mechanism of miR-210 derived from CPCs exosomes in cardiac protection in recent years.

Keywords: MiRNA-210; biomarkers; cardiac progenitor cells; cardioprotection; cardiovascular disease; exosomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / pathology
  • Cardiovascular Diseases / prevention & control*
  • Exosomes / genetics*
  • Humans
  • MicroRNAs / genetics*
  • Multipotent Stem Cells / cytology*
  • Multipotent Stem Cells / metabolism
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / metabolism

Substances

  • MIRN210 microRNA, human
  • MicroRNAs